The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News

A Dementia Vaccine? Most Americans Say Yes

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

The Brain as Two Organs; Epstein-Barr and MS; Indigenous Bolivians and Dementia

— News and commentary from the world of neurology and neuroscience

Rare Congenital TORCH Infections Tied to Greater Autism Risk in Kids

Roughly one in five exposed infants may develop autism

Young Woman Lost for Words Months After Stillbirth

Coexisting headache, blurred vision and nausea offer diagnostic clues

Kennedy's New Autism Research Program Aims to Speed Diagnoses

— ARPA-H launches SPECTRA autism research initiative

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Todays Updates

Benign or Malignant? No Way to Tell Radiologically

Case shows importance of accurate preop diagnosis

FDA Advisors Recommend Galleri Multicancer Blood Test

Some panelists had reservations about the test's true benefit, however

FDA Approves New Option for Previously Treated Bile Duct Cancer

— Trial of lirafugratinib showed responses in almost half of patients, with good durability

Latest News

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

— News and commentary from the world of neurology and neuroscience

Roughly one in five exposed infants may develop autism

Coexisting headache, blurred vision and nausea offer diagnostic clues

— ARPA-H launches SPECTRA autism research initiative

News All Time

Alzheimer's Genetic Risk; Underreported Dementia; Exercise or Nap After Sleep Loss?

News and commentary from the world of neurology and neuroscience

Study: Chronic Pain May Really Be 'All in Your Head'

Protein from skull bone marrow appears to play a key role

Autism-Vaccine Researcher Says He Stole $1M in CDC Grant Funds

Extradited Danish physician admits guilt in operating wire fraud scheme

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Is Paxlovid Any Better Than Placebo for Long COVID?

In three major symptom phenotypes, randomized trial finds no benefit

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Alzheimer's and Liver Enzymes; Pivotal Trial Hold; Lasker Awards Honor Brain Science

News and commentary from the world of neurology and neuroscience

Aging Doctors Face a Patchwork of Cognitive Screening Policies, Study Shows

Unlike pilots, judges, and air traffic controllers, physicians rely largely on self-regulation

Trump's Surgeon General Pick Grilled Over Vaccine Stance

"I do not believe childhood vaccines cause autism," Saphier said

Case Report: What Caused This Man's Acute Paralysis?

36-year-old Asian man had epidural steroid injection for persistent back pain after unsuccessful chiropractic treatments

Recommended News For You

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

Recently released national data on drug use and abuse among Americans.

Fixed-Duration Combo Shows Promise for Relapsed MCL

Early, virtual palliative care feasible for advanced lung cancer

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

Recommended Articles For You

The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025 

The Science Behind Imatinib: How It Targets Cancer Cells  

Multidisciplinary Lessons from a Cancer of Unknown Primary 

Transformative Approaches in Hematology for Healthcare Excellence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Herpes virus-based vaccine shows promise in targeting tumors without side effects

2.

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

3.

Fixed-Duration Combo Shows Promise for Relapsed MCL

4.

Could Burnout Become the Employer’s Responsibility?

5.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

1.

Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts

2.

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective

3.

The importance of understanding normal serum osmolality

4.

Biomarkers of Hematopoietic Reserve During Repeated Physiological Stress

5.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

4.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

5.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot